Richard Pzena Alkermes Plc. Transaction History
Pzena Investment Management LLC
- $29.8 Billion
- Q2 2025
A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Alkermes Plc. stock. As of the latest transaction made, Pzena Investment Management LLC holds 7,439 shares of ALKS stock, worth $231,055. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,439Holding current value
$231,055% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$904 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$575 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$255 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$199 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.1B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...